@article{43a98038fded4cbca7f2bb22bed9aa3c,
title = "Neuroimaging in Tourette Syndrome: Research Highlights from 2014 to 2015",
abstract = "Tourette syndrome (TS) is a developmental neuropsychiatric disorder of the central nervous system defined by the presence of chronic tics. While investigations of the underlying brain mechanisms have provided valuable information, a complete understanding of the pathophysiology of TS remains elusive. Neuroimaging methods provide remarkable tools for examining the human brain and have been used to study brain structure and function in TS. In this article, we review TS neuroimaging studies published in 2014–2015. We highlight a number of noteworthy studies due to their innovative methods and interesting findings. Yet, we note that many of the recent studies share common concerns, specifically susceptibility to motion artifacts and modest sample sizes. Thus, we encourage future work to carefully address potential methodological confounds and to study larger samples to increase the potential for replicable results.",
keywords = "Diffusion, Functional connectivity, MRI, Neuroimaging, Spectroscopy, Tic disorders, Tourette syndrome, Tractography, fMRI",
author = "Greene, {Deanna J.} and Schlaggar, {Bradley L.} and Black, {Kevin J.}",
note = "Funding Information: Bradley L. Schlaggar has received grants from NIH (P30HD062171; R21 NS091635), Tourette Association. Funding Information: ? Deanna J. Greene has received grants from NIH (K01 MH104592). Bradley L. Schlaggar has received grants from NIH (P30HD062171; R21 NS091635), Tourette Association. Kevin J. Black has received grants from Tourette Association, NIH (R21 NS091635), Psyadon Pharmaceuticals, Neurocrine Biosciences, Inc., and grants and personal fees from Acadia Pharmaceuticals. In addition, he has a patent #8,463,552 ?Novel methods for medicinal dosage determination and diagnosis,? issued, and a patent application #13/890,198, pending. This article does not contain any studies with human or animal subjects performed by any of the authors. Funding Information: Kevin J. Black has received grants from Tourette Association, NIH (R21 NS091635), Psyadon Pharmaceuticals, Neurocrine Biosciences, Inc., and grants and personal fees from Acadia Pharmaceuticals. In addition, he has a patent #8,463,552 “Novel methods for medicinal dosage determination and diagnosis,” issued, and a patent application #13/890,198, pending. Funding Information: Deanna J. Greene has received grants from NIH (K01 MH104592). Publisher Copyright: {\textcopyright} 2015, Springer International Publishing Switzerland.",
year = "2015",
month = dec,
day = "1",
doi = "10.1007/s40474-015-0062-6",
language = "English",
volume = "2",
pages = "300--308",
journal = "Current Developmental Disorders Reports",
issn = "2196-2987",
number = "4",
}